Evidence map›Paper›PMID 32727456›Full record

ArticleBMC infectious diseases2020

Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study.

Yiping Wei, Weibiao Zeng, Xiangyun Huang, Junyu Li, Xingting Qiu, Huadong Li, Dinghua Liu, Zhaofeng He, Wenzhong Yao, Ping Huang and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 18 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 18 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 18 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Yiping WeiDepartment of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Weibiao ZengDepartment of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xiangyun HuangSuizhou Zengdu Hospital, Suizhou, China.
Junyu LiDepartment of Radiotherapy, Jiangxi Cancer Hospital, NanChang, China.
Xingting QiuDepartment of CT&MRI, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Huadong LiDepartment of Respiratory Medicine, Chongyi County People's Hospital, Ganzhou, China.
Dinghua LiuDepartment of Critical Medicine, Ganzhou Tumor Hospital, Ganzhou, China.
Zhaofeng HeDepartment of Critical Care Medicine, Dingnan People's Hospital, Dingnan, China.
Wenzhong YaoDepartment of Critical Medicine, Anyuan People's Hospital, Ganzhou, China.
Ping HuangDepartment of Infectious Disease, Xingguo People's Hospital, Ganzhou, China.
Chao LiDepartment of Respiratory Medicine, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, China.
Min ZhuDepartment of General Practice, The First People's Hospital of Fuzhou, Fuzhou, China.
Chunlan ZhongDepartment of Pediatric Neurology, Ganzhou Women's and Children's Hospital of Jiangxi Province, Ganzhou, China.
Xingen ZhuNeurosurgery Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jiansheng LiuDepartment of Respiratory Medicine, Ganzhou People's Hospital, No.17 Hongqi Avenue, Ganzhou City, 341000, Jiangxi Province, China. gzliujs@126.com.
Ganzhou People's Hospital · CNSecond Affiliated Hospital of Nanchang University · CNDingxi City People's Hospital · CNFirst Affiliated Hospital of Gannan Medical University · CNIntegrated Chinese Medicine (China) · CNJiangxi Provincial Cancer Hospital · CNNanchang University · CNSuizhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to report the epidemiological and clinical characteristics of hospitalized patients with coronavirus disease-19 (COVID-19) in Zengdu District, Hubei Province, China.

methodsClinical data on COVID-19 inpatients in Zengdu Hospital from January 27 to March 11, 2020 were collected; this is a community hospital in an area surrounding Wuhan and supported by volunteer doctors. All hospitalized patients with COVID-19 were included in this study. The epidemiological findings, clinical features, laboratory findings, radiologic manifestations, and clinical outcomes of these patients were analyzed. The patients were followed up for clinical outcomes until March 22, 2020. Severe COVID-19 cases include severe and critical cases diagnosed according to the seventh edition of China's COVID-19 diagnostic guidelines. Severe and critical COVID-19 cases were diagnosed according to the seventh edition of China's COVID-19 diagnostic guidelines.

resultsAll hospitalized COVID-19 patients, 276 (median age: 51.0 years), were enrolled, including 262 non-severe and 14 severe patients. The proportion of patients aged over 60 years was higher in the severe group (78.6%) than in the non-severe group (18.7%, p < 0.01). Approximately a quarter of the patients (24.6%) had at least one comorbidity, such as hypertension, diabetes, or cancer, and the proportion of patients with comorbidities was higher in the severe group (85.7%) than in the non-severe group (21.4%, p < 0.01). Common symptoms included fever (82.2% [227/276]) and cough (78.0% [218/276]). 38.4% (106/276) of the patients had a fever at the time of admission. Most patients (94.9% [204/276]) were cured and discharged; 3.6% (10/276) deteriorated to a critical condition and were transferred to another hospital. The median COVID-19 treatment duration and hospital stay were 14.0 and 18.0 days, respectively.

conclusionsMost of the COVID-19 patients in Zengdu had mild disease. Older patients with underlying diseases were at a higher risk of progression to severe disease. The length of hospital-stay and antiviral treatment duration for COVID-19 were slightly longer than those in Wuhan. This work will contribute toward an understanding of COVID-19 characteristics in the areas around the core COVID-19 outbreak region and serve as a reference for decision-making for epidemic prevention and control in similar areas.

Indexed as

AdolescentAdultBetacoronavirusChildChild, PreschoolChinaComorbidityCoronavirus InfectionsCoughCOVID-19COVID-19 Drug TreatmentFemaleFeverHumansHypertensionInfantClinical characteristicsCOVID-19EchocardiographySARS-CoV-2

Identifiers

PMID32727456
PMCPMC7388483
OpenAlexW3046145296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.